[ad_1]
Higher doses of the vitamin can help C. It is being studied in the treatment of Corona virus in some people, but researchers exploring its potential in aging say the main factors of effectiveness include the levels of the natural transporter needed to get the vitamin into the body’s cells. .
Age, race, gender, expression levels, and genetic differences of vitamin C vectors can all be effective factors for vitamin C therapy against Crown And other diseases.
C vitamin
College of Medicine researchers recommend the Georgia Center for Healthy Aging in the Journal of Aging and Disease magazine“That these factors are considered when designing and implementing clinical trials and when study results are analyzed, compared to COVID-19 As well as other cases.
They write that the new nature and lack of immunity against the coronavirus has prompted the world to seek effective treatments for Corona, and this includes the reuse of drugs with known safety features, including vitamin C, which is a booster for the system. immune system and an antioxidant, which made it a logical option to explore in COVID-19.
At least 30 clinical trials are underway evaluating vitamin C, alone or in combination with other therapies Crown Some are at doses up to 10 times the recommended dose of 65-90 mg per day of vitamin C.
Dr Carlos M Isalis, co-director of the MCG Center for Healthy Aging and head of the MCG division on healthy aging, says factors such as whether or not vitamin C enters the cell could be a problem with the effectiveness of treatments that eventually show endocrine diseases Endocrinology, diabetes and metabolism.
According to a co-author of the study, without enough transporters on the cell surface to obtain a water-soluble vitamin beyond the lipid layer of cell membranes, particularly high doses can aid in the formation of the vitamin around the outside of cells where it actually begins to produce oxidants. Like reactive species that damage oxygen rather than help eliminate them.
However, its use in other problems caused by the virus, such as fatal sepsis, has shown its benefit in reducing organ failure and improving lung function in acute respiratory distress syndrome, which is also a major cause. of illness and death due to COVID-19.
At the time of publication of their research on aging and disease, there were still no published studies on the effectiveness of the ongoing high-dose vitamin IV studies for COVID-19.
Researchers have shown that certain conditions, such as osteoporosis and even normal aging, are associated with a significant decrease in the regulation of at least one subtype of the vitamin C transporter.
Many of the highest-risk people are at greater risk of developing diabetes COVID-19 , Including elderly, black and male individuals who have chronic medical conditions such as osteoporosis, hypertension and diabetes, due to low levels of the vitamin. C. Another reason that can be considered vitamin therapy C..
The researchers also note that patients can develop a vitamin C deficiency over the course of their illness COVID-19 Where the vitamin is consumed C. At an increased rate during an active infection, insufficient levels can increase the damage from the overactive immune response.
.
[ad_2]
Source link
